← Back to Search

Immersive Video Games for Cognitive Impairment (Quest-Tablet Trial)

N/A
Recruiting
Led By Peter E Wais, PhD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline immediately before (t1) and post-assessment immediately after training regimen is completed (t2) providing for a composite score t2-t1

Summary

This trial shows promise for restoring memory capability in older adults and patients with cognitive impairment using immersive video games.

Who is the study for?
This trial is for older adults with memory issues or mild cognitive impairment. Participants must have good vision (with glasses if needed), be fluent in English, have completed at least 12 years of education, and be able to operate a response box. They should also be physically able to take brisk walks and not have conditions that make fMRI scans unsafe.
What is being tested?
The study tests whether immersive video games can improve memory by changing brain activity. It uses LabyrinthVR software and other similar tools compared against placebo games to see if they can help restore memory functions or provide therapeutic benefits.
What are the potential side effects?
Potential side effects may include discomfort with virtual reality experiences such as dizziness or nausea, especially for those who already experience vestibular or balance problems.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline immediately before training regimen begins
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline immediately before training regimen begins for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
MDT change in mnemonic discrimination
TOUR change in recall
Task-based cortical functional connectivity associated with mnemonic discrimination capability and in control of sustained visual attention
+1 more
Secondary study objectives
Remote Cognitive Module (RCM)

Trial Design

4Treatment groups
Experimental Treatment
Placebo Group
Group I: LabyrinthVR ScootExperimental Treatment1 Intervention
Multi-session cognitive intervention with VIVE high-resolution head-mounted display virtual reality computer game that presents an adaptive spatial wayfinding challenge. Game movement via handheld controllers.
Group II: Labyrinth VR wirelessExperimental Treatment1 Intervention
Multi-session cognitive intervention with QUEST head-mounted display virtual reality computer game using wireless technology to present an adaptive spatial wayfinding challenge. Game movement via handheld controllers.
Group III: Labyrinth TabletExperimental Treatment1 Intervention
Multi-session cognitive intervention with tablet computer, displaying 2.5D version of Labyrinth game in an adaptive spatial wayfinding challenge. Game movement via on-screen control buttons.
Group IV: Placebo ControlsPlacebo Group1 Intervention
Multi-session cognitive intervention with handheld tablet or wireless virtual reality headset presentation of commercially available, narrative computer games.

Find a Location

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor
2,587 Previous Clinical Trials
14,900,976 Total Patients Enrolled
Peter E Wais, PhDPrincipal InvestigatorNeuroscape, Department of Neurology
1 Previous Clinical Trials
50 Total Patients Enrolled

Media Library

Wayfinding Intervention Clinical Trial Eligibility Overview. Trial Name: NCT05625425 — N/A
Mild Cognitive Impairment Research Study Groups: LabyrinthVR Scoot, Placebo Controls, Labyrinth Tablet, Labyrinth VR wireless
Mild Cognitive Impairment Clinical Trial 2023: Wayfinding Intervention Highlights & Side Effects. Trial Name: NCT05625425 — N/A
Wayfinding Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05625425 — N/A
~113 spots leftby Dec 2025